Ask AI
S. 3742

Cancer Drug Parity Act of 2018

Cancer Drug Coverage Act of 2018

This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sen. Smith, Tina [D-MN](D-MN)Sponsor
5 cosponsors3 D2 R
5cosponsors1committees2actions1related bills5subjects
  1. IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. IntroReferral10000

    Introduced in Senate

Cancer Drug Parity Act of 2018 — Informed